Research areas and methodologies

Clinical research on factors predisposing to the development of the most advanced forms of chronic metabolic liver disease (MAFLD/NASH) including the search for new genetic polymorphisms and the development of new prognostic scores.
Innovative treatments for primary biliary cholangitis (PBC) and MAFLD/NASH.
Emergence of the underground in the epidemiology of chronic HCV hepatitis: scouting mini-invasive treatment of HCV positive patients in nursing homes.
Characterization and pharmacological correction of sarcopenia in patients with chronic liver disease and hepato-oncological pathology.
Noninvasive characterization of benign and malignant nodular liver disease using temporary elastometry.

Collaborations with other Research Centers

  • Gothenburg University, Sweden
  • Universidad de Navarra, Spain
  • Magna Graecia University, Catanzaro, Italy
  • University of Rome, Tor Vergata, Italy
  • Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
  • IRCCS Ca' Granda Foundation Ospedale Maggiore Policlinico, Milan, Italy